Over 100 Years of Continuity

1873

Pharmacist Samuel Benoni Siegfried founds a company with 12 employees as a supplier to pharmacies.

1904

Conversion into a joint stock corporation.

1937

Founding of Ganes Chemical Works, Inc. (NJ, U.S.A.).

1973

Quotation on the Swiss Stock Exchange (SWX) in Basel.

1991

Focus on custom manufacturing and development.

2001

Establishment of two core divisions: Siegfried and Sidroga.

2002

Integration of Ganes into the Siegfried Group to become Siegfried (U.S.A.) Inc.

2004

Establishment of a representative office in Shanghai.

2005 

Acquisition of Penick Corporation in New Jersey, U.S.A.

2006

Corporation agreement with Celgene.

2007

Launch of a pharmaceutical production facility in Malta.
Building up of an entity for inhalation technology in Munich. 
Sale of the Sidroga Division and the biotechnology division.
Corporation agreement with Arena Pharmaceuticals.
Launch of a development facility for inhalation products in Munich.

2008

Sale of the pharmaceutical production site at Zofingen to Arena Pharmaceuticals